Reply to E. Vicente et al

Affiliations

¹ Inserm, US14-Orphanet, Paris, France. ana.rath@inserm.fr.
² Orphanet Ireland, National Rare Diseases Office, Mater Misericordiae University Hospital, Dublin, Ireland.
³ Inserm, US14-Orphanet, Paris, France.
⁴ Eurordis - Rare Diseases Europe, Plateforme Maladies Rares, Paris, France.

Comment

Ana Rath et al. Eur J Hum Genet. 2021 Jun.

. 2021 Jun;29(6):1034-1035.

doi: 10.1038/s41431-020-00764-y. Epub 2020 Dec 1.

¹ Inserm, US14-Orphanet, Paris, France. ana.rath@inserm.fr.
² Orphanet Ireland, National Rare Diseases Office, Mater Misericordiae University Hospital, Dublin, Ireland.
³ Inserm, US14-Orphanet, Paris, France.
⁴ Eurordis - Rare Diseases Europe, Plateforme Maladies Rares, Paris, France.

No abstract available

Conflict of interest statement

The authors declare that they have no conflict of interest.

Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database.
Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, Murphy D, Le Cam Y, Rath A. Nguengang Wakap S, et al. Eur J Hum Genet. 2020 Feb;28(2):165-173. doi: 10.1038/s41431-019-0508-0. Epub 2019 Sep 16. Eur J Hum Genet. 2020. PMID: 31527858 Free PMC article.
Regarding the estimations of people affected by rare diseases.
Vicente E, Pruneda L, Ardanaz E. Vicente E, et al. Eur J Hum Genet. 2021 Jun;29(6):1032-1033. doi: 10.1038/s41431-020-00763-z. Epub 2020 Dec 1. Eur J Hum Genet. 2021. PMID: 33262443 Free PMC article. No abstract available.

1. Orphanet. Procedural document on epidemiology of rare diseases in Orphanet, February 2019, Number 01. 2019. https://www.orpha.net/orphacom/cahiers/docs/GB/Epidemiology_in_Orphanet_.... Accessed October 2020.
1. Gatta G, van der Zwan JM, Casali PG, Siesling S, Dei Tos AP, et al. RARECARE working group. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer. 2011;47:2493–511. doi: 10.1016/j.ejca.2011.08.008. - DOI - PubMed
1. Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28:165–73. doi: 10.1038/s41431-019-0508-0. - DOI - PMC - PubMed
1. Genetic Alliance UK, 2016. The hidden costs of rare disease: a feasilbility study. https://geneticalliance.org.uk/wp-content/uploads/2016/06/hidden-costs-f.... Accessed October 2020.
1. Juggling care and daily life. The balancing act of the rare disease community. A Rare Barometer survey. http://download2.eurordis.org.s3.amazonaws.com/rbv/2017_05_09_Social%20s.... Accessed October 2020.